14 Firmen mit Ergebnissen für "cash"

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

114 Ergebnisse für "cash" unter Somagenetix

Free cash flow, issuance costs, and stock prices - Zurich Open Repo...

... Copy Abstract We develop a dynamic model of a firm facing agency costs of free cash flow and ... frictions affect issuance and dividend policies, the value of cash holdings, and the dynamics of stock ... Free cash flow, issuance costs, and stock prices - Zurich Open Repository and Archive ... Free cash flow, issuance costs, and stock prices - Zurich Open Repository and Archive Header ... Free cash flow, issuance costs, and stock prices - Zurich Open Repository and Archive ...

Cash sub-additive risk measures and interest rate ambiguity - Zuric...

... El Karoui, Nicole ; Ravanelli, Claudia (2009). Cash sub-additive risk measures and interest rate ... ambiguity. Mathematical Finance, 19(4):561-590. Copy Abstract A new class of risk measures called cash sub ... Cash sub-additive risk measures and interest rate ambiguity - Zurich Open Repository and Archive ... Cash sub-additive risk measures and interest rate ambiguity - Zurich Open Repository and Archive ... Cash sub-additive risk measures and interest rate ambiguity - Zurich Open Repository and Archive ...

Mehr Ergebnisse

Bio-Technopark Schlieren-Zürich

http://www.bio-technopark.ch/  

8952 Schlieren, Wagistrasse 23

 +41 76 336 99 44
 mario.jenni@bio-technopark.ch

The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.

Bio-Technopark Schlieren-Zürich

Wagistrasse 23

8952 Schlieren

22 Ergebnisse für "cash" unter Bio-Technopark Schlieren-Zürich

Interim Management Statement Q1 2022 of Molecular Partners: Cash Ru...

... News Interim Management Statement Q1 2022 of Molecular Partners: Cash Runway into 2026 and ... its right to in-license global rights to ensovibep, we are leveraging our strong cash position to ... Interim Management Statement Q1 2022 of Molecular Partners: Cash Runway into 2026 and Portfolio ... - cash-runway-into-2026-and-portfolio-progress-highlight-strategic-momentum/ ... Interim Management Statement Q1 2022 of Molecular Partners: Cash Runway into 2026 and Portfolio ...

Kuros Biosciences reports results for the full year 2018 › BIO-TECH...

... the U.S. and Europe, after first sales were recorded in 2018. CHF 19.0 million cash & cash equivalents ... Europe, after first sales were recorded in 2018. Financial highlights: CHF 19.0 million cash & cash ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

166 Ergebnisse für "cash" unter University of Zurich

From sacred cow to cash cow: The shifting political ecologies of pr...

... Müller, Martin (2014). From sacred cow to cash cow: The shifting political ecologies of protected ... cash cows. It concludes that the neoliberal impetus of introducing market principles into conservation ... From sacred cow to cash cow: The shifting political ecologies of protected areas in Russia - Zurich ... From sacred cow to cash cow: The shifting political ecologies of protected areas in Russia - Zurich ... From sacred cow to cash cow: The shifting political ecologies of protected areas in Russia - Zurich ...

Show Publication

... interbank market get imbalanced towards more cash provider relative to cash taker quotes and the trading ... the financial system, quoted volumes in the interbank market get imbalanced towards more cash provider ... relative to cash taker quotes and the trading volume declines. By estimating liquidity in an interbank repo ...

Mehr Ergebnisse

Kuros Biosciences AG

https://kurosbio.com/  

8952 Schlieren, Wagistrasse 25

 +41 (0)44 733 4747

Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Kuros Biosciences AG

Wagistrasse 25

8952 Schlieren

47 Ergebnisse für "cash" unter Kuros Biosciences AG

Kuros reports 149% increase in direct MagnetOs sales and exceeds ca...

... reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of ... 11% Cash and cash equivalents amounted to CHF 15.8 million, compared to CHF 14.3 million as of June ... Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first ... https://kurosbio.com/resources/kuros-reports-149-increase-in-direct-magnetos-sales-and-exceeds- cash ... Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first ...

... .......................................................................................................................... 5 Consolidated statements of cash flows ... allocation results in a goodwill of CHF 9.9 million. Higher cash reserves due to capital increase Funds ... .......................................................................................................................... 5 Consolidated statements of cash flows ... allocation results in a goodwill of CHF 9.9 million. Higher cash reserves due to capital increase Funds ...

Mehr Ergebnisse

CSL Vifor

https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor  

8952 Schlieren, Zürcherstrasse 39D

 +41 58 851 80 00

Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

CSL Vifor

Zürcherstrasse 39D

8952 Schlieren

92 Ergebnisse für "cash" unter CSL Vifor

CSL Annual Report 2023 – Page 117

... 1 116 Table of Contents 118 172 CSL Annual Report 2023 Consolidated Statement of Cash Flows For the ... Year Ended 30 June 2023 Consolidated Entity Notes 2023 US$m 2022 US$m Cash Flows from Operating ... Consolidated Statement of Cash Flows For the Year Ended 30 June 2023 Consolidated Entity Notes 2023 US$m 2022 ... US$m Cash Flows from Operating Activities Profit before income tax expense 2,663 2,780 Adjustments ...

CSL Annual Report 2022 – Page 103

... 1 102 Table of Contents 104 156 CSL Annual Report 2022 Consolidated Statement of Cash Flows For the ... Year Ended 30 June 2022 Consolidated Entity Notes 2022 US$m 2021 US$m Cash Flows from Operating ... Consolidated Statement of Cash Flows For the Year Ended 30 June 2022 Consolidated Entity Notes 2022 US$m 2021 ... US$m Cash Flows from Operating Activities Profit before income tax expense 2,779.6 2,963.1 ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

138 Ergebnisse für "cash" unter ETH Entrepreneurship

... German version is provided for information purposes only and has no legal force. Directive on cash ... 20191: 1 General provisions 1.1 Purpose ETH Zurich provides the possibility to withdraw or deposit cash ... German version is provided for information purposes only and has no legal force. Directive on cash ... 20191: 1 General provisions 1.1 Purpose ETH Zurich provides the possibility to withdraw or deposit cash ...

IBT MRTM – Biomedical Imaging - MR Technology and Methods | ETH Zurich

... "Advances in High-Field NMR Magnetometry". It carries a CHF 10'000 cash prize and includes project funding ... Magnetometry". It carries a CHF 10'000 cash prize and includes project funding for 18 months. Congratulations ...

Mehr Ergebnisse

Molecular Partners AG

http://www.molecularpartners.com  

8952 Schlieren, Wagistrasse 14

 +41 44 755 77 00

Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.

Molecular Partners AG

Wagistrasse 14

8952 Schlieren

13 Ergebnisse für "cash" unter Molecular Partners AG

QUARTERLY MANAGEMENT STATEMENT FOR THE PERIOD ENDING SEPTEMBER 30, ...

... Financial Highlights: Strengthened financial position with CHF 221 million in cash and cash equivalents at ... net profit of CHF 5.5 million in the third quarter of 2015 Positive cash flow from operations of CHF ... CHF 221 million in cash and cash equivalents at September 30, 2015, up 26% since June 2015 and 130 ... quarter of 2015 Positive cash flow from operations of CHF 43.3 million in the third quarter of 2015 ...

Molecular Partners 1H 2015 Release - Molecular Partners

... company Financial Highlights: CHF 176 million in cash and cash equivalents at 30 June 2015 – will be ... further reinforced through collections of already announced milestone payments Cash-wise the company ... , Chief Medical Officer – a key hire for the company Financial Highlights: CHF 176 million in cash and ... cash equivalents at 30 June 2015 – will be further reinforced through collections of already announced ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

9 Ergebnisse für "cash" unter University Hospital Zurich​, Research and Education Office

Billing for International Patients – USZ

... in cash. Please note that we can only accept cash payments up to CHF 10,000. We request that you ... cash. Please note that we can only accept cash payments up to CHF 10,000. We request that you transfer ...

Lost & found office – USZ

... Hospital Zurich declines all liability. You can deposit valuables and cash at the reception. lost & found ... Hospital Zurich declines all liability. You can deposit valuables and cash at the reception. lost & found ...

Mehr Ergebnisse

Standortförderung Kanton Zürich

https://www.zh.ch/de/volkswirtschaftsdirektion/amt-fuer-wirtschaft/standortfoerderung.html  

8090 Zürich, Walchestrasse 19

 +41 43 259 49 92
 standort@vd.zh.ch

The Division of Business and Economic Development supports resident companies, promotes Zurich's innovation capacity by way of connecting the relevant stakeholders in key industries, fosters external economic relations and offers guidance to companies interested in moving to Zurich.

Standortförderung Kanton Zürich

Walchestrasse 19

8090 Zürich

5 Ergebnisse für "cash" unter Standortförderung Kanton Zürich

Fatherhood, child maintenance and parental custody

... are sub-divided into cash maintenance and childcare maintenance. Cash mainte- nance is intended to ... cover cash expenses for the child. This includes the cost of food, clothing and accommodation and for ... are sub-divided into cash maintenance and childcare maintenance. Cash mainte- nance is intended to ... cover cash expenses for the child. This includes the cost of food, clothing and accommodation and for ...

Ratingbericht Fitch 2020

... ‘Stronger’ risk profile reflects a limited risk that the canton’s cash flow will contract beyond ... to pay for its cash holdings, and the canton now aims to finance more of its maturing debt in the ... ‘Stronger’ risk profile reflects a limited risk that the canton’s cash flow will contract beyond ... to pay for its cash holdings, and the canton now aims to finance more of its maturing debt in the ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

14 Ergebnisse für "cash" unter Roche Glycart AG

Roche - Roche on track – full year earnings outlook increased

... percentage points to 38.1% of sales (+ 1.8 percentage points in local currencies). Operating free cash flow ... performance has allowed us to both increase operating cash flows and to continue to invest in our strong ... ). Operating free cash flow advances significantly by 27 % in local currencies (+7% in Swiss francs) and ... 0 17.9 17.7 Core operating profit 8,251 9,159 -10 +5 38.1 37.2 Operating free cash flow 6,856 6,426 ...

Lung Cancer

... data from STARTRK-NG Desai AV, Robinson GW, Basu EM, Foster JH, Sabnis AJ, Maese L, Yoon J, Cash T ... Desai AV, Robinson GW, Basu EM, Foster JH, Sabnis AJ, Maese L, Yoon J, Cash T, Pratilas CA, Wu Y ...

Mehr Ergebnisse

Mehr Firmen

Nach oben